UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

MRI-guided focused ultrasound: new hope for drug-resistant neurological conditions

Journal of neurology, 2023-11, Vol.270 (11), p.5671-5673

2023

Volltextzugriff (PDF)

Clinical patterns in CADASIL

Journal of neurology, 2022-08, Vol.269 (8), p.4575-4577

2022

Volltextzugriff (PDF)

A role for the Epstein–Barr virus in multiple sclerosis aetiology?

Journal of neurology, 2022-07, Vol.269 (7), p.3962-3963

2022

Volltextzugriff (PDF)

Clinical trials in myasthenia gravis

Journal of neurology, 2023-09, Vol.270 (9), p.4579-4581

2023

Volltextzugriff (PDF)

New approaches in the management of intracranial haemorrhage

Journal of neurology, 2024-09, Vol.271 (9), p.6393-6395

2024

Volltextzugriff (PDF)

Cerebral venous thrombosis: clinical predictors and emerging treatments

Journal of neurology, 2020-10, Vol.267 (10), p.3112-3114

2020

Volltextzugriff (PDF)

Physical activity as a risk factor for amyotrophic lateral sclerosis-findings from three large European cohorts

Journal of neurology, 2020-07, Vol.267 (7), p.2173-2175

2020

Volltextzugriff (PDF)

Cerebral amyloid angiopathy: an update

Journal of neurology, 2023-05, Vol.270 (5), p.2809-2811

2023

Volltextzugriff (PDF)

Multiple sclerosis: early indicators of disease and assessing future risk

Journal of neurology, 2020-11, Vol.267 (11), p.3436-3438

2020

Volltextzugriff (PDF)

Systemic complement profiling in multiple sclerosis as a biomarker of disease state

Multiple sclerosis, 2012-10, Vol.18 (10), p.1401-1411

2012

Volltextzugriff (PDF)

Complement in multiple sclerosis: its role in disease and potential as a biomarker

Clinical and experimental immunology, 2009-02, Vol.155 (2), p.128-139

2009

Volltextzugriff (PDF)

Age at onset as a determinant of presenting phenotype and initial relapse recovery in multiple sclerosis

Multiple sclerosis, 2012-01, Vol.18 (1), p.45-54

2012

Volltextzugriff (PDF)

Alemtuzumab for multiple sclerosis: Long term follow-up in a multi-centre cohort

Multiple sclerosis, 2016-08, Vol.22 (9), p.1215-1223

2016

Volltextzugriff (PDF)

Technology-assisted recovery of walking after spinal cord injury

Journal of neurology, 2019-04, Vol.266 (4), p.1046-1048

2019

Volltextzugriff (PDF)

Increasing prevalence and incidence of multiple sclerosis in South East Wales

Journal of neurology, neurosurgery and psychiatry, 2009-04, Vol.80 (4), p.386-391

2009

Volltextzugriff (PDF)

Multiple sclerosis and the risk of infection: considerations in the threat of the novel coronavirus, COVID-19/SARS-CoV-2

Journal of neurology, 2020-05, Vol.267 (5), p.1567-1569

2020

Volltextzugriff (PDF)

Prevalence and age of onset of Parkinson’s disease in Cardiff: a community based cross sectional study and meta-analysis

Journal of neurology, neurosurgery and psychiatry, 2009-07, Vol.80 (7), p.805-807

2009

Volltextzugriff (PDF)

Alemtuzumab for multiple sclerosis: a new age of immunotherapy

Journal of neurology, 2013, Vol.260 (1), p.343-345

Robertson, N. P.

2013

Volltextzugriff (PDF)

Socioeconomic status in neurological disorders: a modifiable risk factor?

Journal of neurology, 2022-06, Vol.269 (6), p.3385-3386

2022

Volltextzugriff (PDF)

Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy

Journal of neurology, 2022-01, Vol.269 (1), p.534-536

2022

Volltextzugriff (PDF)

Vaccine-induced immune thrombosis and thrombocytopaenia: incidence, mechanism and treatment

Journal of neurology, 2021-11, Vol.268 (11), p.4396-4397

2021

Volltextzugriff (PDF)

Neurological complications of COVID-19: a preliminary review

Journal of neurology, 2020-06, Vol.267 (6), p.1870-1873

2020

Volltextzugriff (PDF)

Neurology and vaccinations: considerations in the context of COVID-19/SARS-COV-2

Journal of neurology, 2021-05, Vol.268 (5), p.2002-2004

2021

Volltextzugriff (PDF)

Campath 1-H treatment in patients with aggressive relapsing remitting multiple sclerosis

Journal of neurology, 2008-02, Vol.255 (2), p.231-238

2008

Volltextzugriff (PDF)

Alemtuzumab in the treatment of IVIG-dependent chronic inflammatory demyelinating polyneuropathy

Journal of neurology, 2010-06, Vol.257 (6), p.913-919

2010

Volltextzugriff (PDF)

1 – 25 von 3.500

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.072)
Mit Volltextzugriff
(2.949)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(2.258)
Life Sciences & Biomedicine
(1.501)
Humans
(1.188)
Female
(731)
Biological And Medical Sciences
(724)
Male
(636)
Physical Sciences
(607)
Medical Sciences
(571)
Adult
(429)
Physics
(386)
Middle Aged
(359)
Animals
(334)
Astronomy & Astrophysics
(240)
Technology
(238)
Aged
(235)
Neurosciences & Neurology
(215)
Adolescent
(201)
Fundamental And Applied Biological Sciences. Psychology
(199)
Child
(174)
Neurosciences
(168)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Free E-Journal (出版社公開部分のみ）
(1.567)
MEDLINE
(1.467)
IngentaConnect
(1.381)
Journals@Ovid Ovid Full Text
(1.163)
Publisher website
(976)
Elsevier ScienceDirect Journals Complete
(675)
IngentaConnect Journals
(547)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(496)
Wiley-Blackwell Journals
(418)
Wiley Online Library Full Collection 2018
(266)
2022 ECC(Springer)
(260)
American Physical Society Journals
(235)
Oxford Journals
(205)
Jstor Complete Legacy
(188)
PROLA
(185)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(180)
Nature Journals Online
(149)
Oxford Journals 2020 Medicine
(142)
BMJ_英国医学会期刊
(112)
BMJ Journals Archiv - DFG Nationallizenzen
(87)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(5)
... seit 90 Tagen
(22)

Menü

Weitere Dienste

Einstellungen

MRI-guided focused ultrasound: new hope for drug-resistant neurological conditions

Clinical patterns in CADASIL

A role for the Epstein–Barr virus in multiple sclerosis aetiology?

Clinical trials in myasthenia gravis

New approaches in the management of intracranial haemorrhage

Cerebral venous thrombosis: clinical predictors and emerging treatments

Physical activity as a risk factor for amyotrophic lateral sclerosis-findings from three large European cohorts

Cerebral amyloid angiopathy: an update

Multiple sclerosis: early indicators of disease and assessing future risk

Systemic complement profiling in multiple sclerosis as a biomarker of disease state

Complement in multiple sclerosis: its role in disease and potential as a biomarker

Age at onset as a determinant of presenting phenotype and initial relapse recovery in multiple sclerosis

Alemtuzumab for multiple sclerosis: Long term follow-up in a multi-centre cohort

Technology-assisted recovery of walking after spinal cord injury

Increasing prevalence and incidence of multiple sclerosis in South East Wales

Multiple sclerosis and the risk of infection: considerations in the threat of the novel coronavirus, COVID-19/SARS-CoV-2

Prevalence and age of onset of Parkinson’s disease in Cardiff: a community based cross sectional study and meta-analysis

Alemtuzumab for multiple sclerosis: a new age of immunotherapy

Socioeconomic status in neurological disorders: a modifiable risk factor?

Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy

Vaccine-induced immune thrombosis and thrombocytopaenia: incidence, mechanism and treatment

Neurological complications of COVID-19: a preliminary review

Neurology and vaccinations: considerations in the context of COVID-19/SARS-COV-2

Campath 1-H treatment in patients with aggressive relapsing remitting multiple sclerosis

Alemtuzumab in the treatment of IVIG-dependent chronic inflammatory demyelinating polyneuropathy

Suchergebnisse filtern